DOCK2 and prostate carcinoma: DOCK2 as a guanine nucleotide exchange factor (GEF) belongs to the dedicators of cytokinesis (DOCK) family, which originally identified in hematopoietic cell, and now it is also studied in B‐cell lymphoma and prostate cancer.38